| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Q32 Bio Inc. | CEO, Director | Stock Option (Right to Buy) | 394,445 | $5,293,452 | $13.42 | 24 Feb 2025 | Direct |
| Q32 Bio Inc. | CEO, Director | Common Stock | 99,000 | $342,540 | $3.46 | 02 Dec 2025 | Direct |
| AILERON THERAPEUTICS INC | Director | Stock Option (right to buy) | 54,500 | 15 Jun 2022 | Direct | ||
| Verve Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 25 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QTTB | Q32 Bio Inc. | 02 Dec 2025 | 1 | -$77,871 | 4 | CEO, Director | 04 Dec 2025, 19:00 |
| QTTB | Q32 Bio Inc. | 26 Aug 2025 | 1 | -$18,900 | 4 | CEO, Director | 28 Aug 2025, 19:32 |
| VERV | Verve Therapeutics, Inc. | 25 Jul 2025 | 2 | $0 | 4 | Director | 28 Jul 2025, 17:15 |
| VERV | Verve Therapeutics, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 17:00 |
| QTTB | Q32 Bio Inc. | 24 Feb 2025 | 9 | $0 | 4 | CEO, Director | 26 Feb 2025, 21:59 |
| VERV | Verve Therapeutics, Inc. | 26 Jun 2024 | 1 | $0 | 4 | Director | 28 Jun 2024, 07:45 |
| VERV | Verve Therapeutics, Inc. | 26 Jun 2024 | 0 | $0 | 3 | Director | 28 Jun 2024, 07:30 |
| QTTB | Homology Medicines, Inc. | 25 Mar 2024 | 1 | $0 | 4 | CEO, Director | 27 Mar 2024, 17:36 |
| QTTB | Homology Medicines, Inc. | 25 Mar 2024 | 0 | $0 | 3 | CEO, Director | 27 Mar 2024, 17:22 |
| RNTX | AILERON THERAPEUTICS INC | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 17:22 |
| RNTX | AILERON THERAPEUTICS INC | 15 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 19:55 |